Friday Briefing: Israel Expands Evacuation Orders in Lebanon
The Israeli military issued evacuation warnings for 20 more towns and villages in southern Lebanon, signaling a potential ...
bovnews4h
Gilead Sciences, Inc. (GILD) Stock Price Reaches $84.74: What Factors Are Influencing This Level?
On Wednesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.74 which represents a slight increase of $0.80 or 0.95% from the prior close of $83.94. The stock opened at ...
Gilead to donate remdesivir for emergency use against Marburg disease in Rwanda
The drug is being supplied in conjunction with Rwanda's health ministry and the Africa Centers for Disease Control, Gilead ...
GILD Grants Right for HIV PrEP Candidate to Six Generic Companies
Gilead signs non-exclusive, royalty-free voluntary licensing agreements with six generic companies to market its ...
Biopharma firm Gilead announces lenacapavir licensing for HIV treatment
International AIDS Society, an association of HIV/AIDS professionals, applauded moves by Gilead Sciences, a biopharma company ...
The Stranger7h
Slog AM: Virginia Mason To Close Downtown Birth Center, Grand Illusion To Move (Hopefully), A Fat Bear Slayed
Surprise: Hannah and I switched Slog days. Because I respect tradition, we’ll begin with the weather, which is quite nice ...
BioSpace7h
Gilead Partners With Generics Developers to Provide HIV Drug to Low-Income Countries
Gilead Sciences is granting licenses to six companies to produce lenacapavir for pre-exposure prophylaxis, as well as for ...
Gilead inks pact with six generic drugmakers on long-acting HIV injectable, even as civil society oppose patent application
Six drugmakers sign agreements with Gilead Sciences to produce generic lenacapavir, a long-acting HIV drug, amid patent ...
IAS Calls For Global Access As Gilead Announces Lenacapavir Licensing
3 October 2024 (Geneva, Switzerland) – IAS – the International AIDS Society – applauds moves by Gilead Sciences to make generic injectable lenacapavir for HIV prevention widely available, but cautions ...
India Today9h
Indian pharma firms sign deal to produce, sell generic HIV drug lenacapavir
Indian pharmaceutical companies are set to produce generic versions of lenacapavir, an HIV prevention drug, under agreements ...
Daily9h
Gilead Sciences inks pacts with Dr Reddy's Labs, Emcure, Hetero and 3 others for HIV drug Lenacapavir
Gilead Sciences, Inc. has announced that it has signed non-exclusive, royalty-free voluntary licensing agreements with six ...
STAT9h
Dockworker strike puts drug supplies at risk
How supplies of GLP-1 drugs could be at risk as a result of the dockworker strike occurring across the East and Gulf coasts: ...